Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02897908 · ClinicalTrials.gov registry record
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
A clinical trial of Disease of Liver and Bile Duct, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02897908 is a study of Disease of Liver and Bile Duct that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02897908, a study of Disease of Liver and Bile Duct, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.
Conditions Studied
Interventions
- PROCEDURE vibration controlled transient elastography (VCTE)
Study Locations (1)
New York
- Conventus Medical Office Building - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-10-28 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02897908
The ClinicalTrials.gov registry entry for NCT02897908 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Disease of Liver and Bile Duct appearing as the primary indexed condition, and to 1 intervention - of which vibration controlled transient elastography (VCTE) is the first listed.
NCT02897908 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02897908 about?
NCT02897908 is a clinical study titled "Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database". The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.
What is the current status of trial NCT02897908?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-10-28. Estimated completion is 2026-12.
What conditions does trial NCT02897908 study?
This clinical trial studies the following conditions: Disease of Liver and Bile Duct.
What interventions are being tested in trial NCT02897908?
The interventions under investigation include: vibration controlled transient elastography (VCTE) (PROCEDURE).
Who is sponsoring clinical trial NCT02897908?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02897908 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.